论文部分内容阅读
我院自１９９１年１月至今共行尸肾栓植术４４４例．出现肝功能衰竭（ｈｅｐａｔｉｃｆａｉｌｕｒｅ，ＨＦ）９例，其中７例为ＨＢｓＡｇ或ＨＢｅＡｇ和ＨＢｓＡｇ阳性，２例ＨＣＶ抗体阳性，术后ＨＦ分别占ＨＢｓＡｇ和ＨＣＶ抗体阳性患者的１３．７％和２０％，总发病率为２．０２％。ＨＦ早期病情隐匿，起病急，病程短，与病毒性肝炎关系密切，治疗棘手，且并发症多，多伴有严重感染，预后极差。本组９例全部死亡，严重影响患者及移植肾的长期存活。本文对ＨＦ的发病原因、临床特性、治疗及预后、预防进行了分析和讨论。
Our hospital since January 1991 has so far carried out corpse renal embolisation 444 cases. There were 9 cases of hepatic failure (HF), of which 7 cases were positive for HBsAg or HBeAg and HBsAg, 2 cases were positive for HCV antibody, and postoperative HF accounted for 13.7% and 20% respectively of patients with HBsAg and HCV antibody positive The incidence was 2.02%. HF early occult disease, acute onset, short course, closely linked with viral hepatitis, the treatment of intractable, and complications, and more with severe infection, the prognosis is extremely poor. All 9 patients died in this group, seriously affecting the long-term survival of patients and transplant kidneys. In this paper, the causes of HF, clinical features, treatment and prognosis, prevention were analyzed and discussed.